Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization

Di Fan, Laura A. Coughlin, Megan M. Neubauer, Jiwoong Kim, Min Soo Kim, Xiaowei Zhan, Tiffany R Simms-Waldrip, Yang Xie, Lora V Hooper, Andrew Koh

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Candida albicans colonization is required for invasive disease. Unlike humans, adult mice with mature intact gut microbiota are resistant to C. albicans gastrointestinal (GI) colonization, but the factors that promote C. albicans colonization resistance are unknown. Here we demonstrate that commensal anaerobic bacteria - specifically clostridial Firmicutes (clusters IV and XIVa) and Bacteroidetes - are critical for maintaining C. albicans colonization resistance in mice. Using Bacteroides thetaiotamicron as a model organism, we find that hypoxia-inducible factor-1α (HIF-1α), a transcription factor important for activating innate immune effectors, and the antimicrobial peptide LL-37 (CRAMP in mice) are key determinants of C. albicans colonization resistance. Although antibiotic treatment enables C. albicans colonization, pharmacologic activation of colonic Hif1a induces CRAMP expression and results in a significant reduction of C. albicans GI colonization and a 50% decrease in mortality from invasive disease. In the setting of antibiotics, Hif1a and Camp (which encodes CRAMP) are required for B. thetaiotamicron-induced protection against C. albicans colonization of the gut. Thus, modulating C. albicans GI colonization by activation of gut mucosal immune effectors may represent a novel therapeutic approach for preventing invasive fungal disease in humans.

Original languageEnglish (US)
Pages (from-to)808-814
Number of pages7
JournalNature Medicine
Volume21
Issue number7
DOIs
StatePublished - Jun 8 2015

Fingerprint

Hypoxia-Inducible Factor 1
Candida
Candida albicans
Bacteria
Chemical activation
Anti-Bacterial Agents
Transcription Factors
Activating Transcription Factors
Bacteroidetes
Bacteroides
Anaerobic Bacteria
Mycoses

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization. / Fan, Di; Coughlin, Laura A.; Neubauer, Megan M.; Kim, Jiwoong; Kim, Min Soo; Zhan, Xiaowei; Simms-Waldrip, Tiffany R; Xie, Yang; Hooper, Lora V; Koh, Andrew.

In: Nature Medicine, Vol. 21, No. 7, 08.06.2015, p. 808-814.

Research output: Contribution to journalArticle

@article{7f79160b3a664b6493cb017f59d64bcc,
title = "Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization",
abstract = "Candida albicans colonization is required for invasive disease. Unlike humans, adult mice with mature intact gut microbiota are resistant to C. albicans gastrointestinal (GI) colonization, but the factors that promote C. albicans colonization resistance are unknown. Here we demonstrate that commensal anaerobic bacteria - specifically clostridial Firmicutes (clusters IV and XIVa) and Bacteroidetes - are critical for maintaining C. albicans colonization resistance in mice. Using Bacteroides thetaiotamicron as a model organism, we find that hypoxia-inducible factor-1α (HIF-1α), a transcription factor important for activating innate immune effectors, and the antimicrobial peptide LL-37 (CRAMP in mice) are key determinants of C. albicans colonization resistance. Although antibiotic treatment enables C. albicans colonization, pharmacologic activation of colonic Hif1a induces CRAMP expression and results in a significant reduction of C. albicans GI colonization and a 50{\%} decrease in mortality from invasive disease. In the setting of antibiotics, Hif1a and Camp (which encodes CRAMP) are required for B. thetaiotamicron-induced protection against C. albicans colonization of the gut. Thus, modulating C. albicans GI colonization by activation of gut mucosal immune effectors may represent a novel therapeutic approach for preventing invasive fungal disease in humans.",
author = "Di Fan and Coughlin, {Laura A.} and Neubauer, {Megan M.} and Jiwoong Kim and Kim, {Min Soo} and Xiaowei Zhan and Simms-Waldrip, {Tiffany R} and Yang Xie and Hooper, {Lora V} and Andrew Koh",
year = "2015",
month = "6",
day = "8",
doi = "10.1038/nm.3871",
language = "English (US)",
volume = "21",
pages = "808--814",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization

AU - Fan, Di

AU - Coughlin, Laura A.

AU - Neubauer, Megan M.

AU - Kim, Jiwoong

AU - Kim, Min Soo

AU - Zhan, Xiaowei

AU - Simms-Waldrip, Tiffany R

AU - Xie, Yang

AU - Hooper, Lora V

AU - Koh, Andrew

PY - 2015/6/8

Y1 - 2015/6/8

N2 - Candida albicans colonization is required for invasive disease. Unlike humans, adult mice with mature intact gut microbiota are resistant to C. albicans gastrointestinal (GI) colonization, but the factors that promote C. albicans colonization resistance are unknown. Here we demonstrate that commensal anaerobic bacteria - specifically clostridial Firmicutes (clusters IV and XIVa) and Bacteroidetes - are critical for maintaining C. albicans colonization resistance in mice. Using Bacteroides thetaiotamicron as a model organism, we find that hypoxia-inducible factor-1α (HIF-1α), a transcription factor important for activating innate immune effectors, and the antimicrobial peptide LL-37 (CRAMP in mice) are key determinants of C. albicans colonization resistance. Although antibiotic treatment enables C. albicans colonization, pharmacologic activation of colonic Hif1a induces CRAMP expression and results in a significant reduction of C. albicans GI colonization and a 50% decrease in mortality from invasive disease. In the setting of antibiotics, Hif1a and Camp (which encodes CRAMP) are required for B. thetaiotamicron-induced protection against C. albicans colonization of the gut. Thus, modulating C. albicans GI colonization by activation of gut mucosal immune effectors may represent a novel therapeutic approach for preventing invasive fungal disease in humans.

AB - Candida albicans colonization is required for invasive disease. Unlike humans, adult mice with mature intact gut microbiota are resistant to C. albicans gastrointestinal (GI) colonization, but the factors that promote C. albicans colonization resistance are unknown. Here we demonstrate that commensal anaerobic bacteria - specifically clostridial Firmicutes (clusters IV and XIVa) and Bacteroidetes - are critical for maintaining C. albicans colonization resistance in mice. Using Bacteroides thetaiotamicron as a model organism, we find that hypoxia-inducible factor-1α (HIF-1α), a transcription factor important for activating innate immune effectors, and the antimicrobial peptide LL-37 (CRAMP in mice) are key determinants of C. albicans colonization resistance. Although antibiotic treatment enables C. albicans colonization, pharmacologic activation of colonic Hif1a induces CRAMP expression and results in a significant reduction of C. albicans GI colonization and a 50% decrease in mortality from invasive disease. In the setting of antibiotics, Hif1a and Camp (which encodes CRAMP) are required for B. thetaiotamicron-induced protection against C. albicans colonization of the gut. Thus, modulating C. albicans GI colonization by activation of gut mucosal immune effectors may represent a novel therapeutic approach for preventing invasive fungal disease in humans.

UR - http://www.scopus.com/inward/record.url?scp=84936891126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936891126&partnerID=8YFLogxK

U2 - 10.1038/nm.3871

DO - 10.1038/nm.3871

M3 - Article

C2 - 26053625

AN - SCOPUS:84936891126

VL - 21

SP - 808

EP - 814

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 7

ER -